NCT00878839WithdrawnNot Applicable
Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Alcon Research
- Primary Endpoint
- Corneal Aberration
Study Overview
Brief Summary
A prospective evaluation of postoperative corneal aberrations and visual parameters (e.g. visual acuity) in patients implanted with an AcrySof Toric IOL.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Operable cataracts;
- •Good ocular health;
- •Qualifies for AcrySof Toric IOL via AcrySof Toric Calculator (1.03-2.06 D cylinder at corneal plane)
Exclusion Criteria
- •>2.06 D astigmatism at corneal plane;
- •irregular astigmatism;
- •prior or ongoing corneal disease or scarring;
- •history of ocular disease
Outcomes
Primary Outcomes
Corneal Aberration
Time Frame: 3 months
Secondary Outcomes
- Visual acuity, residual refractive cylinder, lens alignment(3 months)
Investigators
Similar Trials
Withdrawn
Phase 4
Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) PatientsCataractsNCT00929747Alcon Research
Completed
Not Applicable
A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)CataractAstigmatismNCT01045733Alcon Research70
Completed
Not Applicable
Visual Outcomes With a Trifocal IOL in Subjects With Open-angle GlaucomaIOLCataractGlaucoma, Open-AngleNCT04619654Vold Vision P.L.L.C25
Completed
Not Applicable
Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular LensesCataractNCT02985723Carl Zeiss Meditec AG120
Withdrawn
Not Applicable
Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland DysfunctionModerate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)NCT01692665Yonsei University
